Guidelines for Tums (Calcium Carbonate) and Heartburn
First-Line Recommendation
For occasional, episodic heartburn, calcium carbonate antacids like Tums provide rapid symptom relief within minutes and are appropriate for self-treatment, but patients requiring frequent use (more than twice weekly for over 2 weeks) should be evaluated by a physician and transitioned to proton pump inhibitor therapy. 1, 2
Dosage and Administration
Standard Dosing
- Tums Extra Strength (750 mg tablets): Provides 300 mg elemental calcium per tablet 3
- Tums Ultra (1,000 mg tablets): Provides 400 mg elemental calcium per tablet 3
- Typical dose: 2-4 tablets chewed thoroughly as needed for heartburn symptoms 4
- Maximum daily intake: Should not exceed 2,500 mg elemental calcium from all sources (approximately 8 Tums Extra Strength tablets) 3
Timing Considerations
- Chew tablets thoroughly rather than swallowing whole to maximize surface area for acid neutralization 5, 4
- Can be taken with or without meals, though most effective when taken at symptom onset 4
- For meal-induced heartburn, combining low-dose H2-receptor antagonist (ranitidine 75 mg) with calcium carbonate provides synergistic benefit 6
Mechanism and Duration of Action
Onset and Duration
- Onset: Calcium carbonate begins neutralizing esophageal acid within 5-10 minutes 4
- Duration of esophageal effect: Approximately 60 minutes 4
- Duration of gastric effect: Minimal, with potential for acid rebound in the stomach 4
Unique Mechanisms Beyond Acid Neutralization
- Calcium released from chewed antacids improves esophageal peristalsis by increasing proximal esophageal contractile amplitude and decreasing distal onset velocity 5
- This motor effect may contribute to improved acid clearance independent of pH neutralization 5
Indications for Medical Evaluation
Red Flags Requiring Physician Assessment
Patients should stop self-treatment and seek medical evaluation if they experience:
- Heartburn requiring antacid use more than twice weekly for over 2 weeks 1, 2
- Daily heartburn symptoms despite antacid use 7
- Heartburn duration exceeding 3 months 7
- Troublesome dysphagia (difficulty swallowing) 3
- Unintentional weight loss 3
- Gastrointestinal bleeding (black stools, vomiting blood) 3
Why Frequent Use Warrants Evaluation
- 47% of patients with chronic heartburn requiring frequent antacids have underlying esophageal pathology including erosive esophagitis, Barrett's esophagus, or even adenocarcinoma 7
- Chronic symptoms may reflect significant acid exposure (mean total esophageal acid contact time elevated) despite normal-appearing mucosa on endoscopy in 53% of cases 7
- Self-medication masks symptoms without addressing underlying disease progression 2, 7
Contraindications and Precautions
Absolute Contraindications
- Hypercalcemia (elevated blood calcium levels) 3
- Severe renal impairment (calcium accumulation risk) 3
- History of calcium-containing kidney stones 3
Relative Contraindications and Cautions
- Chronic kidney disease: Limit calcium intake to 100% of age-specific DRI; avoid exceeding 2,500 mg/day total calcium 3
- Patients on digoxin: Hypercalcemia from excessive calcium carbonate can precipitate digoxin toxicity 3
- Achlorhydria or taking PPIs: Calcium carbonate requires gastric acid for optimal absorption; calcium citrate is preferred alternative 3
Drug Interactions
- Decreases absorption of tetracycline antibiotics, fluoroquinolones, levothyroxine, and bisphosphonates—separate dosing by at least 2 hours 3
- Acid rebound phenomenon: Calcium carbonate can paradoxically stimulate gastric acid secretion after initial neutralization, potentially worsening symptoms 4
When to Transition to Prescription Therapy
Step-Up Algorithm
- Occasional heartburn (≤2 episodes/week): Calcium carbonate antacids as needed 1, 2
- Frequent heartburn (>2 episodes/week): Initiate standard-dose PPI (omeprazole 20 mg daily, lansoprazole 30 mg daily) taken 30-60 minutes before breakfast 1
- Inadequate response after 4-8 weeks: Increase to twice-daily PPI dosing before meals 3, 1
- Failure of twice-daily PPI: Perform endoscopy with biopsy to evaluate for erosive esophagitis, Barrett's esophagus, eosinophilic esophagitis, or alternative diagnoses 3, 1
Why PPIs Are Superior for Chronic Symptoms
- PPIs provide significantly faster and more complete symptomatic relief compared to H2-receptor antagonists and antacids for chronic GERD 2
- PPIs heal erosive esophagitis in 85-94% of patients within 8 weeks, whereas antacids only provide symptomatic relief without healing 1, 2
- PPIs prevent relapse of erosive esophagitis significantly better than H2-receptor antagonists 2
Common Pitfalls to Avoid
Clinical Errors
- Do not continue empiric antacid therapy beyond 2 weeks for frequent symptoms without physician evaluation—this delays diagnosis of potentially serious conditions 1, 7
- Do not assume normal endoscopy excludes GERD—53% of patients with chronic heartburn have normal-appearing mucosa but abnormal acid exposure on pH monitoring 7
- Do not use calcium citrate preparations (like Citracal) as phosphate binders in CKD patients—they enhance aluminum absorption and are not recommended 3
- Do not exceed 2,500 mg elemental calcium daily from all sources (diet plus supplements) to avoid hypercalcemia, constipation, and potential cardiovascular risks 3
Patient Education Points
- Antacids treat symptoms, not disease—they do not heal esophagitis or prevent complications of chronic GERD 2
- Calcium carbonate causes constipation in some patients; aluminum/magnesium hydroxide combinations (Mylanta, Maalox) may be better tolerated 4
- Chewing is essential—swallowing tablets whole dramatically reduces efficacy 5, 4
Adjunctive Lifestyle Modifications
While initiating antacid therapy, implement these evidence-based measures:
- Elevate head of bed 6-8 inches for nighttime symptoms 1
- Avoid trigger foods (alcohol, coffee, chocolate, spicy foods) if they consistently provoke symptoms 1
- Weight loss for overweight/obese patients reduces need for long-term acid suppression 1
- Avoid eating within 3 hours of bedtime to reduce nocturnal acid exposure 1